A5090799498- Multiple and Secondary Primary Cancers
- Bladder and Urothelial Cancer Treatments
- Health Systems, Economic Evaluations, Quality of Life
- Economic and Financial Impacts of Cancer
- Patient-Provider Communication in Healthcare
- Cancer survivorship and care
- Acute Lymphoblastic Leukemia research
- Meta-analysis and systematic reviews
- Cardiac Arrhythmias and Treatments
- Cancer Genomics and Diagnostics
- Atrial Fibrillation Management and Outcomes
- Acute Myeloid Leukemia Research
- Inhalation and Respiratory Drug Delivery
- Pharmaceutical Economics and Policy
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Inflammatory Bowel Disease
- Gestational Trophoblastic Disease Studies
- Cancer Diagnosis and Treatment
- Cardiac electrophysiology and arrhythmias
- Clinical practice guidelines implementation
- Global Cancer Incidence and Screening
Precision Research (United States)
2024
Precision for Medicine (United States)
2023
4570 Background: Real-world studies have shown that a majority of pts with la/mUC do not receive first-line (1L) systemic therapy (tx), despite guideline recommendations. This cross-sectional study assessed the criteria Eu5 physicians consider when making decisions about 1L tx for la/mUC. Methods: A quantitative online survey was performed in Aug-Sep 2022. Respondents answered questions related to demographics, practice patterns, and considered decision-making. Descriptive statistics were...
696 Background: The standard of care for mUC is platinum-based chemotherapy (PBC) followed by avelumab first-line (1L) maintenance in patients without disease progression. Guidelines recommend 1L treatment based on eligibility PBC (cisplatin or carboplatin), but the definition PE remains unclear, and little known about criteria used European physicians to define clinical practice. In this cross-sectional study, we assessed decision-making factors thresholds determine examined their alignment...
Background. Over the last 25 years, clinical practice guidelines have emerged as a means to standardize and improve care. As pharmaceutical innovations develop, are updated incorporate new interventions. However, extent which pharmacotherapies represented treatment options in guideline recommendations has not been well elucidated. This study aimed quantify role pharmacotherapy played across range of chronic diseases over past 20 years. Methods. Clinical published from 2000 2021 were...
PURPOSE: Medical management of patients with chronic obstructive pulmonary disease (COPD) includes nebulized maintenance therapy.During the COVID-19 pandemic, there is a heightened concern SARS-CoV-2 transmission among on nebulizers, causing some health care providers to discontinue therapy long-acting bronchodilators COPD in long-term (LTC) facilities.The study objective was compare outcomes between who discontinued nebulizer versus those did not.METHODS: Using PointClickCare's Lighthouse...